SEARCH

SEARCH BY CITATION

References

  • 1
    Third report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III): final report. Circulation. 2002;106:31433421.
  • 2
    Centers for Disease Control and Prevention. National diabetes fact sheet: general information and national estimates on diabetes in the United States, 2007. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, 2008. http://www.cdc.gov/diabetes/pubs/pdf/ndfs_2007.pdf. Accessed July 27, 2009.
  • 3
    Grundy SM, Benjamin IJ, Burke GL, et al. Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation. 1999;100: 11341146.
  • 4
    Bax JJ, Inzucchi SE, Bonow RO, et al. Cardiac imaging for risk stratification in diabetes. Diabetes Care. 2007;30:12951304.
  • 5
    Kang X, Berman DS, Lewin H, et al. Comparative ability of myocardial perfusion single-photon emission computed tomography to detect coronary artery disease in patients with and without diabetes mellitus. Am Heart J. 1999;137:949957.
  • 6
    Vanzetto G, Halimi S, Hammoud T, et al. Prediction of cardiovascular events in clinically selected high-risk NIDDM patients. Diabetes Care. 1999;22:1926.
  • 7
    Giri S, Shaw LJ, Murthy DR, et al. Impact of diabetes on the risk stratification using stress single-photon emission computed tomography myocardial perfusion imaging in patients with symptoms suggestive of coronary artery disease. Circulation. 2000;105: 3240.
  • 8
    Berman DS, Kang X, Hayes SW, et al. Adenosine myocardial perfusion single-photon emission computed tomography in women compared with men. J Am Coll Cardiol. 2003;41:11251133.
  • 9
    Miller TD, Rajagopalan N, Hodge DO, et al. Yield of stress single-photon emission computed tomography in asymptomatic patients with diabetes. Am Heart J. 2004;147: 890896.
  • 10
    Wackers FJ, Young LH, Inzucchi SE, et al. Detection of Ischemia in Asymptomatic Diabetics Investigators. Detection of silent myocardial ischemia in asymptomatic diabetic subject. Diabetes Care. 2004;27:19541961.
  • 11
    DeLuca AJ, Saulle LN, Aronor WS, et al. Prevalence of silent myocardial ischemia in persons with diabetes mellitus or impaired glucose tolerance and association of hemoglobin A1C with prevalence of silent myocardial ischemia. Am J Cardiol. 2005;95: 14721473.
  • 12
    Ravipati G, Aronow WS, Ahn C, et al. Association of hemoglobin A1C level with severity of coronary artery disease in patients with diabetes mellitus. Am J Cardiol. 2006;97:968969.
  • 13
    UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complication in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352: 837853.
  • 14
    Mostaza JM, Gomez MV, Gallardo F, et al. Cholesterol reduction improves myocardial perfusion abnormalities in patients with coronary artery disease and average cholesterol levels. J Am Coll Cardiol. 2000;35:7682.
  • 15
    Wackers FJ, Chyun DA, Young LH, et al. Detection of Ischemia in Asymptomatic Diabetics (DIAD) Investigators. Resolution of asymptomatic myocardial ischemia in patients with type 2 diabetes in the detection of ischemia in asymptomatic diabetics (DIAD) study. Diabetes Care. 2007;30:28922898.
  • 16
    Mahmarian JJ, Dakik HA, Filipchuk NG, et al. An initial strategy of intensive medical therapy is comparable to that of coronary revascularization for suppression of scintigraphic ischemia in high-risk but stable survivors of acute myocardial infarction. J Am Coll Cardiol. 2006;48:24582467.
  • 17
    Selvin E, Steffes MW, Zhu H, et al. Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N Engl J Med. 2010;362:800811.